肾功能测试市场规模、份额和成长分析：按产品、按测试、按最终用户、按地区 - 行业预测，2024-2031

肾功能检测市值将从 2023 年的 8.9515 亿美元增至 2022 年的 8.421 亿美元，预测期内（2024-2031 年）复合年增长率为 6.3%，到 2031 年将达到 14.594 亿美元。美元。

由于多种因素推动该行业向前发展，肾功能检测市场可望大幅扩张。关键影响因素包括大型市场参与企业的大量投资和加强研发力度，这两者都在推动肾臟护理领域的创新。一个关键因素是肾臟疾病的高盛行率，促使人们采取积极的方法来加强诊断和治疗。政府措施在营造有利于创新进步的环境方面也发挥着重要作用。例如，2022 年 3 月，Nova Biomedical 宣布将透过在传统医院环境之外的即时检测 (POCT) 环境中促进早期疾病检测和肾功能筛检来彻底改变肾臟护理，我们为此宣布了一种革命性工具。临床研究已经在社区健康中心、药房、诊断影像中心、医生办公室、诊所甚至家庭测试等非医院环境中检验了有效性。这项创新有望扩大肾臟健康评估的范围，透过先进的诊断功能丰富多样化的环境，并实现积极的医疗保健措施以改善患者的治疗效果。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 关键成功因素
• 市场吸引力指数
• 竞争程度
• 关键投资机会
• 生态系绘图

肾功能检测市场：依产品分类

• 市场概况
• 量油尺
• 一次性的
• 试剂

肾功能检测市场：按检测

• 市场概况
• 尿液检查
  • 尿蛋白检测
  • 肌酸酐清除率测试
  • 微量白蛋白测试
• 验血
  • 血清肌酸酐测试
  • 肾小球滤过率测试
  • 血中尿素氮检查
• 其他的

肾功能检测市场：依最终用户分类

• 市场概况
• 诊断实验室
• 医院
• 研究所/机构
• 其他的

肾功能检测市场规模：按地区划分

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Roche Diagnostics（Switzerland）
• Beckman Coulter Inc.（USA）
• Sysmex Corporation（Japan）
• Randox Laboratories Ltd.（UK）
• ACON Laboratories, Inc.（USA）
• Nova Biomedical（USA）
• ARKRAY, Inc.（Japan）
• 77 Elektronika Kft.（Hungary）
• Opti Medical Systems, Inc.（USA）
• Quest Diagnostics（USA）
• Ortho Clinical Diagnostics（USA）
• Merck KGaA（Germany）
• Danaher Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• LabCorp（USA）
• DiaSys Diagnostic Systems GmbH（Germany）
• Thermo Fisher Scientific Inc.（USA）
• URIT Medical Electronic Co., Ltd.（China）

Kidney Function Test Market was valued at USD 842.1 million in 2022 and is expected to rise from USD 895.15 million in 2023 to reach a value of USD 1459.4 million by 2031, at a CAGR of 6.3% during the forecast period (2024-2031).

The Kidney function test market is positioned for significant expansion driven by multiple factors advancing the field. Key contributors include substantial investments by major market players and increased research and development efforts, both driving innovations in Kidney care. A primary catalyst is the high prevalence of kidney diseases, prompting a proactive approach to enhance diagnostics and treatment. Government initiatives also play a crucial role in fostering a conducive environment for transformative advancements. For instance, Nova Biomedical introduced a groundbreaking tool in March 2022 designed to revolutionise Kidney care by facilitating early disease detection and renal function screening in Point-of-Care Testing (POCT) settings outside traditional hospital settings. Clinical studies have validated its efficacy across non-hospital environments, such as community health centres, pharmacies, imaging centres, physician offices, clinics, and even home-based testing. This innovation promises to expand access to Kidney health assessment, empowering diverse settings with advanced diagnostic capabilities and enabling proactive healthcare measures for better patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Kidney Function Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Kidney Function Test Market Segmental Analysis

The kidney function tests market is segmented into product, test, end-user, and region. Based on product, the market is segmented into dipsticks, disposables, and reagents. Based on tests, the market is segmented into urine tests (urine protein tests, creatinine clearance tests, microalbumin tests), blood tests (serum creatinine tests, glomerular filtration rate tests, blood urea nitrogen tests), and others. Based on end user, the market is segmented into diagnostic laboratories, hospital, research laboratories & institute and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Drivers of the Kidney Function Test Market

The Kidney function test market is experiencing significant growth opportunities propelled by advancements in technology. One such milestone is the innovative system launched by Bloom Diagnostics in August 2022, which introduces a sophisticated approach to detecting a wide range of medical conditions. Central to their offerings is the Bloom Kidney Test, a cutting-edge addition that transforms the assessment of Kidney health. This test introduces a quantitative measurement of cystatin C levels in the blood, enabling precise evaluation of the Glomerular Filtration Rate (GFR) for determining Kidney functionality. It categorizes results into three clear classifications-normal function, mildly decreased function, or decreased function-providing crucial insights into overall Kidney health status. This advancement marks a significant leap forward in enhancing diagnostic capabilities and patient care in nephrology.

Restraints in the Kidney Function Test Market

The expanding Kidney function tests market encounters substantial barriers due to the expensive nature of these diagnostic procedures, especially affecting emerging and underdeveloped countries. The high costs hinder the widespread adoption of these vital tests, creating disparities in access to essential healthcare diagnostics. This affordability gap further exacerbates inequities, limiting early detection and intervention for kidney-related illnesses in these regions, thereby perpetuating health inequalities. In regions with emerging economies or underdeveloped healthcare infrastructure, the costliness of kidney function tests presents a formidable obstacle. These diagnostic procedures are crucial for detecting and managing kidney-related conditions early, yet their high expense restricts their accessibility to a privileged few. This disparity not only obstructs the widespread adoption of essential healthcare measures but also deepens existing inequalities in medical care. Consequently, many individuals in these areas face delayed diagnoses and treatments for kidney ailments, amplifying the burden of preventable health complications. Thus, addressing the financial barriers to kidney function tests is pivotal for promoting more equitable healthcare outcomes globally.

Market Trends of the Kidney Function Test Market

The rising popularity of home diagnostics, exemplified by the growing use of digital urinalysis, is significantly boosting market expansion. This trend underscores a shift towards more convenient and accessible healthcare options. Healthy.io, an Israeli digital health startup, has adeptly identified this trend and introduced an FDA-approved smartphone urinalysis test designed specifically for individuals needing kidney function tests for proteins. This innovation not only meets the increasing demand for personalized healthcare solutions but also illustrates the transformative impact of technology on empowering individuals to monitor their health conveniently from home. In recent times, there has been a notable surge in the demand for home diagnostic tools, particularly digital urinalysis, which is fueling substantial growth in this market segment. This trend reflects a broader movement towards healthcare solutions that prioritize convenience and accessibility. An example of this shift can be seen in Healthy.io, an Israeli digital health startup, which has responded effectively by developing an FDA-cleared smartphone urinalysis test designed for individuals seeking kidney function assessments for proteins. This innovative approach not only caters to the growing need for personalized health monitoring but also demonstrates how technology can empower individuals to manage their health conveniently at home.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Kidney Function Test Market by Product

• Market Overview
• Dipsticks
• Disposables
• Reagents

Kidney Function Test Market by Test

• Market Overview
• Urine Test
  • Urine Protein Tests
  • Creatinine Clearance Tests
  • Microalbumin Tests
• Blood Test
  • Serum Creatinine Tests
  • Glomerular Filtration Rate Tests
  • Blood Urea Nitrogen Tests
• Others

Kidney Function Test Market by End User

• Market Overview
• Diagnostic Laboratories
• Hospital
• Research Laboratories & Institute
• Others

Kidney Function Test Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Opti Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSys Diagnostic Systems GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electronic Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments